secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001493152-26-021019
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Imunon enters change of control severance agreements with CEO, CMO, and GC
--------------------------------------------------------------------------

- CEO Lindborg gets 2.5x base salary plus target bonus severance; others get 1.5x.
- COBRA coverage: 24 months for CEO, 18 months for CMO and GC.
- All unvested equity awards fully accelerate upon qualifying termination in change-of-control window.
- Effective May 1, 2026; trigger period is 4 months before to 1 year after a change of control.
- Benefits require a release of claims; 1-year non-compete covenant applies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000149315226021019/0001493152-26-021019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000149315226021019/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-021019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer